Atracurium Besylate
Active substance: atracurium
INJECTION, SOLUTION · ATRACURIUM BESYLATE 10 mg/mL
United StatesActive
Marketing holder: Meitheal Pharmaceuticals Inc.
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
- Countries with the substance registered: 1
Composition
- ATRACURIUM BESYLATE · 10 mg/mL
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-760c-7a5f-b769-560bfd7a130e,01a1208e-eb83-783e-9a76-990f9a09142d,01a12091-d935-7f80-af52-bd2d743a0a3f,01a1209b-e34d-7a13-bab9-c5a5c4b6db8f,01a1209b-e376-735d-ba08-9ccdf5b3b5c6;count=6 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 71288-701
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- INTRAVENOUS
Sources
- product · openFDA NDC · 71288-701 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 71288-701 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 71288-701 · Verified 2026-10-09 · open in source